Related Experiment Video
Updated: Mar 29, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
A method for quantification of exportin-1 (XPO1) occupancy by Selective Inhibitor of Nuclear Export (SINE) compounds
Marsha L Crochiere1, Erkan Baloglu1, Boris Klebanov1
1All authors are current or former employees of Karyopharm Therapeutics Inc., Newton, MA, 02459 U.S.A.
Abstract:
Selective Inhibitor of Nuclear Export (SINE) compounds are a family of small-molecules that inhibit nuclear export through covalent binding to cysteine 528 (Cys528) in the cargo-binding pocket of Exportin 1 (XPO1/CRM1) and promote cancer cell death. Selinexor is the lead SINE compound currently in phase I and II clinical trials for advanced solid and hematological malignancies. In an effort to understand selinexor-XPO1 interaction and to establish whether cancer cell response is a function of drug-target engagement, we developed a quantitative XPO1 occupancy assay. Biotinylated leptomycin B (b-LMB) was utilized as a tool compound to measure SINE-free XPO1. Binding to XPO1 was quantitated from SINE compound treated adherent and suspension cells in vitro, dosed ex vivo human peripheral blood mononuclear cells (PBMCs), and PBMCs from mice dosed orally with drug in vivo. Evaluation of a panel of selinexor sensitive and resistant cell lines revealed that resistance was not attributed to XPO1 occupancy by selinexor. Administration of a single dose of selinexor bound XPO1 for minimally 72 hours both in vitro and in vivo. While XPO1 inhibition directly correlates with selinexor pharmacokinetics, the biological outcome of this inhibition depends on modulation of pathways downstream of XPO1, which ultimately determines cancer cell responsiveness.
Insights
Selective Inhibitor of Nuclear Export (SINE) compounds target Exportin 1 (XPO1) to kill cancer cells. Cancer cell response to selinexor depends on downstream pathway modulation, not solely XPO1 occupancy.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Selective Inhibitor of Nuclear Export (SINE) compounds target Exportin 1 (XPO1/CRM1) via covalent binding at Cys528.
- Selinexor is a lead SINE compound investigated in clinical trials for advanced cancers.
- Understanding the drug-target engagement of selinexor and XPO1 is crucial for cancer treatment efficacy.
Purpose of the Study:
- To develop a quantitative assay to measure XPO1 occupancy by SINE compounds.
- To investigate the relationship between selinexor-XPO1 interaction and cancer cell response.
- To determine if cancer cell resistance is linked to XPO1 target engagement.
Main Methods:
- Developed a quantitative XPO1 occupancy assay using biotinylated leptomycin B (b-LMB) as a tool compound.
- Quantitated XPO1 binding in various cell models (adherent, suspension, PBMCs) and in vivo mouse models.
- Assessed selinexor sensitivity and resistance in a panel of cancer cell lines.
Main Results:
- Selinexor demonstrated sustained XPO1 binding for at least 72 hours in vitro and in vivo.
- Cancer cell resistance to selinexor was not explained by reduced XPO1 occupancy.
- XPO1 inhibition correlated with selinexor pharmacokinetics, but downstream effects dictated cell response.
Conclusions:
- Selinexor effectively engages its target XPO1, with sustained binding observed.
- Cancer cell responsiveness to selinexor is determined by the modulation of pathways downstream of XPO1.
- The study highlights the importance of downstream signaling in SINE compound efficacy.
More Related Videos
Related Concept Videos
Nuclear Export
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
Regulation of Nuclear Protein Sorting
Directionality of Nuclear Transport
Nuclear Export of mRNA
Nuclear Export of mRNA
Nuclear Protein Sorting
Proteins targeted to the nucleus carry nuclear localization signals or NLS recognized by import receptors in the cytosol. Similarly, proteins with nuclear export signals are recognized by export receptors. Import and export receptors are...

